Mixed connective tissue disease associated with von Recklinghausen's nurofibromatosis

Internal Medicine

Volumn 40, Issue 4, 2001, Pages 363-364

  Migita, Kiyoshi ^a,b   Kawabe, Yojiro ^a   Mori, Masataka ^b   Hirose, Ryoji ^b   Kimura, Hironori ^b   Hamada, Hisayuki ^b   Yano, Michitami ^b   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nagasaki Chuo National Hospital   (Japan)

Author keywords

Anti UIRNP antibody; Autoimmune disease; HLA DR2

Indexed keywords

ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; FEMALE; HUMAN; MIXED CONNECTIVE TISSUE DISEASE; NEUROFIBROMATOSIS; RAYNAUD PHENOMENON;

ADULT; ANTI-INFLAMMATORY AGENTS; ARTHRALGIA; FEMALE; HUMANS; MIXED CONNECTIVE TISSUE DISEASE; NEUROFIBROMATOSIS 1; PREDNISOLONE; RAYNAUD DISEASE;

EID: 0035316835     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.363     Document Type: Article

References (13)

1. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen. Am J Med 52: 148-159, 1972.
2. Riccardi VM, Eichner JE. Neurofibromatosis: phenotype, natural history, and pathogenesis. Johns Hopkins University Press, Baltimore, 1986: 56-149.
3. Kasukawa R. Mixed connective tissue disease. Internal Med 38: 386-393, 1999.
4. Smolen JS, Steiner G. Mixed connective tissue disease: to be or not to be? Arthritis Rheum 41: 768-777, 1998 (see comments).
5. Cervera R, Khamashta MA, Hughes GRV. 'Overlap' syndromes. Ann Rheum Dis 49: 947-948, 1990.
6. Black C, Isenberg D. Mixed connective tissue disease-goodbye to all that. Br J Rheumatol 31: 695-700, 1992.
7. Gerosa PL, Vai C, Bizzozero L, Fontana A, Giussani G, Spinelli M. Immunological and clinical surveillance in Recklinghausen's neurofibromatosi (NF1). Panminerva Med 35: 80-85, 1993.
8. Toch T, Trinn C, Simon L, Nagy J. A case of membranous glomerulonephritis associated with von Recklinghausen's neurofibromatosis. Clin Nephrol 45: 271-272, 1996.
9. Kubota T, Hiki Y, Horii A, Kobayashi Y. Recklinghausen's neurofibromatosis associated with membranous nephropathy. Nephron 65: 486, 1993 (letter).
10. Mikolajczyk-Tobola Z, Okowa H, Reszel I. Rheumatoid arthritis in a patient with v. Recklinghausen's disease after paratyroidectomy. Reumatologia 9: 97-100, 1971.
11. Bitnun S, Bassan H. Letter: Neurofibromatosis and SLE. N Engl J Med 292: 429-430, 1975.
12. Riccardi VM. Neurofibromatosis in a patient with systemic lupus erythematosus. Arthritis Rheum 26: 574, 1983 (letter).
13. Gendi NS, Welsh KI, Von Venrooij WJ, Vancheeswaran R, Gilroy J, Black CM. HLA types as a predictor of mixed connective tissue disease differentiation. Ten-year clinical and immunogenetic followup of 46 patients. Arthritis Rheum 38: 259-266, 1995.